Qatar Recalls All Batches Of Another Eye Drops Product Over Safety Concerns
The Qatari Ministry of Health called on the members of the public who purchased the product to immediately stop using it, while stressing the commitment to patient safety and the quality of pharmaceutical products in the market. The recalling was due to "critical observations related to data integrity and sterile processing at the manufacturing facility".
Recommended For You Soon you will own a flying car that you can drive on the roadIsotears-Plus is a lubricating eye drop solution used for the temporary relief of burning, irritation, and discomfort caused by dry eyes or environmental exposure.
Stay up to date with the latest news. Follow KT on WhatsApp Channels.
The announcement was made three days after recalling all batches of another eye drop, the Clasgen 0.05%, over the same concerns. On November 4, authorities cited "observations at the manufacturing site related to data integrity and sterile manufacturing processes," as reason for the decision.
The eye drops are prescription immunomodulatory eye drops used to treat chronic dry eye disease (keratoconjunctivitis sicca) by reducing underlying surface inflammation and helping restore natural tear production.
It was not immediately clear if both recalling decisions are connected.
ALSO READ- UAE issues recall of affected batch of face masks due to quality concerns Qatar warns against slimming product promoted on social media over potential health risks Dubai recalls affected batches of Baby Sleep Gripe Water for undeclared alcohol content
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept any
responsibility or liability for the accuracy, content, images, videos,
licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright issues
related to this article, kindly contact the provider above.
Comments
No comment